STAQ Pharma logo

STAQ Pharma

Website
Current Valuation
N/A
As of September 12, 2024
Total Funding Raised
$95.8M
Last Round
Later Stage VC

$11.4M

Last Funding
Sep 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

STAQ Pharma is currently valued at N/A as of September 12, 2024. The company has raised a total of $95.8M in funding.

Investment Perspective

STAQ Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track STAQ Pharma Valuation Updates

Get notified when STAQ Pharma raises new funding or valuation changes

Explore More Data
Detailed analysis for STAQ Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is STAQ Pharma Worth in 2025?

As of 2025, STAQ Pharma is valued at N/A, based on the company's Later Stage VC funding round in September 12, 2024. This valuation positions STAQ Pharma as one of the leading private companies in the sector.

STAQ Pharma Valuation History

STAQ Pharma's funding history demonstrates steady growth and investor confidence.

How STAQ Pharma Valuation is Determined

Private company valuations like STAQ Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

STAQ Pharma Valuation FAQs

Is STAQ Pharma profitable?

STAQ Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does STAQ Pharma's valuation compare to competitors?

STAQ Pharma is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will STAQ Pharma IPO?

STAQ Pharma has not announced plans for an initial public offering. Until an IPO, investors can access STAQ Pharma shares through secondary market platforms.